MM

Muzammil Mansuri

Venture Partner at F-Prime Capital

Concord, Massachusetts

Overview 

Muzammil Mansuri is a Venture Partner at F-Prime Capital, specializing in investing in Series A and Seed stages within sectors like Pharmaceuticals, Digital Health, and BioTech. With an impressive background as an EVP at Sanofi and SVP at Gilead Sciences, Mansuri has successfully invested in companies like CHARM Therapeutics at F-Prime Capital.

Work Experience 

FC

F-Prime Capital

  • Venture Partner

    2020 - Current

F-Prime Capital is a venture capital firm investing in healthcare and technology.

fprimecapital.com
S

Sanofi

  • EVP

    2016 - 2019

GS

Gilead Sciences

  • SVP

    2010 - 2016

Gilead Sciences is a biopharmaceutical company that discovers, develops, manufactures and commercializes therapies for critical diseases.

Raised $4,413,500,000.00 from Abingworth.

gilead.com

Investments 

CHARM Therapeutics

Series A

Total funding: $50M

Articles About Muzammil

Relevant Websites